Celloid
Seoul, South Korea· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A South Korean biotech developing stem cell and engineered cell therapies for regenerative medicine.
Regenerative MedicineDegenerative Diseases
Technology Platform
Proprietary stem cell culture, expansion, and differentiation platform for creating standardized therapeutic cell products.
Opportunities
Growing global demand for regenerative therapies and supportive regulatory frameworks in Asia present significant market potential.
Risk Factors
High clinical development risks, complex manufacturing, and stringent regulatory hurdles for cell-based products.
Competitive Landscape
Operates in a crowded but rapidly evolving global cell therapy market, competing with larger biotechs and academic spin-offs on technological differentiation.